BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//REMEDi4ALL - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://remedi4all.org
X-WR-CALDESC:Events for REMEDi4ALL
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Amsterdam
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250506
DTEND;VALUE=DATE:20250507
DTSTAMP:20260422T065454
CREATED:20241112T085350Z
LAST-MODIFIED:20250423T074835Z
UID:8841-1746489600-1746575999@remedi4all.org
SUMMARY:REMEDi4ALL Funders Network Event 2025
DESCRIPTION:Pre-iDR25 REMEDi4ALL Funders Network Event\nIn an exclusive pre-conference meeting\, members and observers of the REMEDi4ALL Funders Network will come together to share best practices and discuss important topics. This meeting will be followed by an evening boat trip on the Amsterdam canals and a Funders Network dinner at IJver restaurant. \nRegister here!\n  \nMeeting location: Royal Netherlands Academy of Arts and Sciences (KNAW)\, Het Trippenhuis\, Kloveniersburgwal 29\, Amsterdam \nDinner location: IJver Restaurant\, Scheepsbouwkade 72\, Amsterdam
URL:https://remedi4all.org/event/2025-remedi4all-funders-network-meeting/
LOCATION:Royal Netherlands Academy of Arts and Sciences (KNAW)\, Het Trippenhuis\, Kloveniersburgwal 29\, 1011 JV\, Amsterdam\, 1011 JV\, Netherlands
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2024/11/iDR25-Workshops-3-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Amsterdam:20250506T120000
DTEND;TZID=Europe/Amsterdam:20250506T183000
DTSTAMP:20260422T065454
CREATED:20241115T092618Z
LAST-MODIFIED:20250414T104630Z
UID:8873-1746532800-1746556200@remedi4all.org
SUMMARY:#iDR25 Pre-Conference Workshops
DESCRIPTION:To kick off the iDR25 conference series\, two exclusive pre-conference workshops will be held on 6th May 2025 at the Royal Netherlands Academy of Arts and Sciences (KNAW). The workshops are primarily aimed at academics\, early career researchers and patient representatives looking to increase the understanding of key topics related to medicines repurposing and gain practical skills to apply to current and future drug repurposing projects. \nRegister today for the pre-iDR25 workshop series!\n  \nWorkshop 1: Health Technology Assessment: a key tool to patient access\nTuesday 6th May 2025\n12:30-14:30\n  \n \nAfter regulatory approval by the EMA\, Health Technology Assessment (HTA) becomes a pivotal process in determining whether new treatments will be accessible to patients\, influencing their affordability\, availability\, and overall impact on healthcare systems. The HTA dossier encapsulates critical information\, including the medical\, economic\, social\, and ethical considerations of using a health technology—such as a repurposed medicine. Prepared by the product developer or sponsor\, these dossiers undergo evaluation by HTA agencies\, like EUnetHTA 21 in the EU or NICE in the UK\, to assess their value and feasibility. \nThis workshop  will equip researchers\, patient representatives and product developers with the knowledge and tools to design their repurposing projects to meet HTA standards from the onset. With a focus on early alignment with HTA requirements\, evidence planning\, and incorporating patient engagement into the HTA process from the beginning\, attendees will gain actionable insights to streamline their projects through HTA evaluations\, enhancing the likelihood of timely patient access. \nThis workshop offers a unique opportunity to learn proactive strategies to maximise the success of drug repurposing projects in achieving their ultimate goal—reaching and benefiting patients. \n  \n[team_member description=”” social=”” link_element=”both” color=”accent-color” image_url=”https://remedi4all.org/wp-content/uploads/2024/11/Dalma-Hosszu.png” name=”Dalma Hosszú” job_position=”Syreon Research Institute” link_url=”https://remedi4all.org/people/idr-speaker/dalma-hosszu/”]\n [team_member description=”” social=”” link_element=”both” color=”accent-color” image_url=”https://remedi4all.org/wp-content/uploads/2024/11/Andras-Perenyi.png” name=”András Perényi” job_position=”Syreon Research Institute” link_url=”https://remedi4all.org/people/idr-speaker/andras-perenyi/”]\n \n \n \n \n  \nWorkshop 2: Navigating the regulatory path for medicinal product repurposing\nTuesday 6th May 2025\n15:00-18:30\n  \n \nIn this workshop\, we will discuss the regulatory path and key milestones for advancing a repurposed/repositioned medicinal product from preclinical development to market authorisation in Europe\, tailored for academic researchers and early-career developers navigating such processes for the first time. Whether you are preparing for your first clinical trial application or strategising for market authorisation\, this session will provide crucial tools and insights to help build your regulatory strategy including: \n\nCore elements of a Clinical Trial Application (CTA)\nObtaining Orphan Drug Designations for rare diseases\nEffective engagement with regulatory authorities (e.g. scientific advice)\nOverview of possible registration pathways to bring promising therapies to patients faster\nBuilding the Common Technical Document (CTD) for a European Marketing Authorisation Application (MAA)\n\nConfirmed speakers \n [team_member description=”” social=”” link_element=”both” color=”accent-color” image_url=”https://remedi4all.org/wp-content/uploads/2024/11/Violeta-_Workshop.png” name=”Violeta Stoyanova-Beninska” job_position=”Human Division of the European Medicines Agency (EMA)” link_url=”https://remedi4all.org/people/idr-speaker/violeta-stoyanova-beninska/”]\n [team_member description=”” social=”” link_element=”both” color=”accent-color” image_url=”https://remedi4all.org/wp-content/uploads/2024/11/Rosan-Vegter.png” name=”Rosan Vegter” job_position=”EATRIS” link_url=”https://remedi4all.org/people/idr-speaker/rosan-vegte/”]\n[team_member description=”” social=”” link_element=”both” color=”accent-color” image_url=”https://remedi4all.org/wp-content/uploads/2024/11/Nadina-Grosios.png” name=”Nadina Grosios” job_position=”Oncoknow” link_url=”https://remedi4all.org/people/idr-speaker/nadina-grosios/”] \n \n \nRegister today for the pre-iDR25 workshop series!\n  \nNote: this event is separate to the main conference. Find out more about iDR25: Medicines Reimagined here. \nQuestions? Contact conference@remedi4all.org.
URL:https://remedi4all.org/event/idr25-pre-conference-workshops/
LOCATION:Royal Netherlands Academy of Arts and Sciences (KNAW)\, Het Trippenhuis\, Kloveniersburgwal 29\, 1011 JV\, Amsterdam\, 1011 JV\, Netherlands
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2024/11/iDR25-Workshops-1-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250507
DTEND;VALUE=DATE:20250509
DTSTAMP:20260422T065454
CREATED:20241007T132248Z
LAST-MODIFIED:20241209T151356Z
UID:8550-1746576000-1746748799@remedi4all.org
SUMMARY:International Drug Repurposing Conference 2025 - #iDR25
DESCRIPTION:Exciting news for anyone passionate about healthcare innovation—iDR25\, the International Drug Repurposing Conference\, is coming up on 7-8th May 2025 in the beautiful city of Amsterdam in The Netherlands!
URL:https://remedi4all.org/event/international-drug-repurposing-conference-2025-idr25/
LOCATION:Amsterdam\, the Netherlands
ATTACH;FMTTYPE=image/png:https://remedi4all.org/wp-content/uploads/2024/09/iDR25-Branding-SoMe-Card.png
END:VEVENT
END:VCALENDAR